Search
for
Sort by
Research 61–90 of 531
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Transcriptome Dynamics Reveal Stage-Specific and Melatonin-Triggered Gene Expression Patterns During The Cashmere Growth Cycle in Capra Hircus
- The Role of Janus Kinase Inhibitors in Dermatology
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- MSC-EVs and UCB-EVs promote skin wound healing and spatial transcriptome analysis
- 915 Dietary grape powder inhibits atopic dermatitis-like skin lesions in NC/Nga mice
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Alopecia areata
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- mTOR signaling in hair follicle and hair diseases: recent progress
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Time-course RNA-seq analysis reveals stage-specific and melatonin-triggered gene expression patterns during the hair follicle growth cycle in Capra hircus
- Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Autoinmune Alopecia/Alopecia Areata
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Exploring the Potential Role of Hydroxytyrosol in Androgenetic Alopecia: An Integrated Bioinformatics and Molecular Simulation Study
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Alopecia areata – Current understanding and management
- Vitiligo—Current Treatment Options and Future Perspectives
- Implication of microRNA regulation in para-phenylenediamine-induced cell death and senescence in normal human hair dermal papilla cells